| Tumor microenvironment heterogeneity: challenges and opportunities F Runa, S Hamalian, K Meade, P Shisgal, PC Gray, JA Kelber Current molecular biology reports 3, 218-229, 2017 | 172 | 2017 |
| Ulocladium systematics revisited: phylogeny and taxonomic status F Runa, MS Park, BM Pryor Mycological progress 8, 35-47, 2009 | 80 | 2009 |
| Identification of a PEAK1/ZEB1 signaling axis during TGFβ/fibronectin-induced EMT in breast cancer M Agajanian, F Runa, JA Kelber Biochemical and biophysical research communications 465 (3), 606-612, 2015 | 50 | 2015 |
| Nuclear heterogeneity in conidial populations of Aspergillus flavus F Runa, I Carbone, D Bhatnagar, GA Payne Fungal genetics and biology 84, 62-72, 2015 | 22 | 2015 |
| A SNAI2-PEAK1-INHBA stromal axis drives progression and lapatinib resistance in HER2-positive breast cancer by supporting subpopulations of tumor cells positive for … S Hamalian, R Güth, F Runa, F Sanchez, E Vickers, M Agajanian, ... Oncogene 40 (33), 5224-5235, 2021 | 20 | 2021 |
| Molecular versus conventional methods: clinical evaluation of different methods for the diagnosis of tuberculosis in Bangladesh F Runa, M Yasmin, MM Hoq, J Begum, ASMM Rahman, CR Ahsan Journal of Microbiology, Immunology and Infection 44 (2), 101-105, 2011 | 19 | 2011 |
| Identification of myosin II as a cripto binding protein and regulator of cripto function in stem cells and tissue regeneration M Hoover, F Runa, E Booker, JK Diedrich, E Duell, B Williams, ... Biochemical and biophysical research communications 509 (1), 69-75, 2019 | 12 | 2019 |
| Ascending the PEAK1 toward targeting TGFβ during cancer progression: recent advances and future perspectives F Runa, Y Adamian, JA Kelber Cancer cell & microenvironment 3 (1), e1162, 2016 | 11 | 2016 |
| Impact of COVID-19 pandemic on rare diseases-A case study on thalassaemia patients in Bangladesh MS Hossain, F Runa, A Al Mosabbir Public Health in Practice 2, 100150, 2021 | 10 | 2021 |
| Patient‐Derived Organoids as Therapy Screening Platforms in Cancer Patients D Khorsandi, JW Yang, S Foster, S Khosravi, ... Advanced Healthcare Materials 13 (21), 2302331, 2024 | 5 | 2024 |
| Targeting SMAD-Dependent Signaling: Considerations in Epithelial and Mesenchymal Solid Tumors. F Runa, G Ortiz-Soto, NR de Barros, JATSDSCEMST Kelber Pharmaceuticals 13 (3), 326, 2024 | 5 | 2024 |
| Tumor microenvironment heterogeneity: challenges and opportunities. Curr Mol Biol Rep. 2017; 3 (4): 218–29 F Runa, S Hamalian, K Meade, P Shisgal, PC Gray, JA Kelber Epub 2018/02/13. doi: 10.1007/s40610-017-0073-7. PubMed PMID: 29430386, 0 | 5 | |
| Fibronectin, DHPS and SLC3A2 signaling cooperate to control tumor spheroid growth, subcellular eIF5A1/2 distribution and CDK4/6 inhibitor resistance C Geller, J Maddela, R Tuplano, F Runa, Y Adamian, R Güth, GO Soto, ... bioRxiv, 2023 | 3 | 2023 |
| Nuclear condition in Aspergillus flavus during growth and conidiation F Runa, I Carbone, GA Payne Genetics of Maize Disease Workshop, 20-23, 2011 | 2 | 2011 |
| Abstract PO5-24-04: Fibronectin, DHPS and SLC3A2 Signaling Cooperate to Control Tumor Spheroid Growth, Subcellular eIF5A1/2 Distribution and CDK4/6 Inhibitor Resistance C Geller, J Maddela, G Ortiz-Soto, R Tuplano, F Runa, Y Adamian, R Güth, ... Cancer Research 84 (9_Supplement), PO5-24-04-PO5-24-04, 2024 | | 2024 |
| Multidimensional screening of pancreatic cancer spheroids reveals vulnerabilities in mitotic and cell-matrix adhesion signaling that associate with metastatic progression and … AF Aquino, F Runa, JF Shoma, A Todd, M Wallace, NR de Barros, ... Biochemical and biophysical research communications 703, 149575, 2024 | | 2024 |
| Retinoic acid induced 14 drives pancreatic cancer progression and metastasis F Runa, L Tomaneng, Y Adamian, N Cox, AF Aquino, M Wallace, ... Cancer Research 82 (12_Supplement), 2414-2414, 2022 | | 2022 |
| A SNAI2-PEAK1 stromal axis drives progression and lapatinib resistance in HER2-positive breast cancer by supporting a cytokine expression profile that converges on PI3K/Akt … S Hamalian, R Güth, F Runa, J Molnar, E Vickers, M Agajanian, ... bioRxiv, 2020.05. 15.098772, 2020 | | 2020 |
| CSUNPOSIUM A STUDENT | | 2019 |
| RAI14 is an actin cytoskeleton interacting protein that is upregulated in pancreatic cancer and promotes Src kinase stability, proliferation and migration JA Runa F, Gonzalez C, Adamian Y, Cox N, Hong J, Bhakta K, Hoover M, Boyce M ... ASCB and EMBO, 2019 | | 2019 |
Jonathan KelberBaylor UniversityVerificeret mail på baylor.edu